Emmanuel Katsanis
University of Arizona · The University of Arizona Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Emmanuel Katsanis as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:45 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07254793 · Prophylactic DLI-X for Leukemia Relapse After HCTUniversity of Arizona · recruiting · Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia (AUL) · principal investigator
- Ph1NCT02996773 · Haploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineUniversity of Arizona · completed · Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndromes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Exercise as an Immune Adjuvant for Gamma Delta T-cell Therapies in Hematologic MalignanciesR01CA277493 · NCI · UNIVERSITY OF ARIZONA · fiscal years 2023 to 2026 · $629,554 awarded in 2026Same name and institution; not confirmed by an ID
- Exercise-Enhanced Off-the-Shelf Allogeneic Cell Therapies for Relapsed LeukemiaR01CA311242 · NCI · UNIVERSITY OF ARIZONA · fiscal years 2026 · $632,905 awarded in 2026Same name and institution; not confirmed by an ID
- Immunotherapy for Chronic Myelogenous LeukemiaR01CA104926 · NCI · UNIVERSITY OF ARIZONA · fiscal years 2004 to 2013 · $248,905 awarded in 2013Same name and institution; not confirmed by an ID
- Chaperone rich cell lysates (CRCL)Natural adjuvants and*R21CA102410 · NCI · UNIVERSITY OF ARIZONA · fiscal years 2003 to 2004 · $225,750 awarded in 2004Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in chronic myeloid leukemia.